NetDragon and Open University Malaysia Sign Strategic MOU to Jointly Explore New Models of AI-Powered Open Education
HONG KONG, Oct. 27, 2025 /PRNewswire/ -- NetDragon Websoft Holdings Limited ("NetDragon" or "the Company"; Hong Kong Stock Code: 777), a global leader in building internet communities, is pleased to announce that it has signed a strategic Memorandum...
Indigenously Designed and Manufactured Laptops by Vyonix Launched at IMC 2025
GURUGRAM, India, Oct. 27, 2025 /PRNewswire/ -- India's 1st indigenously designed and manufactured Laptops, were launched at the India Mobile Congress (IMC) 2025 by Vyonix. Designed, engineered, and manufactured entirely in India for Vyonix by VVDN...
Antengene Presents Latest Preclinical Data of ATG-201 (CD19 x CD3 TCE) at ACR 2025
SHANGHAI and HONG KONG, Oct. 27, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercialising first-in-class...
YeePay Showcases One-Stop Global Payment Solutions at ITB Asia 2025, Empowering the Global Travel Ecosystem
SINGAPORE, Oct. 27, 2025 /PRNewswire/ -- YeePay, a leading digital transaction service provider for the global aviation and travel ecosystem, made a strong appearance at ITB Asia 2025, Asia's largest B2B travel trade show, held from October 15–17 at...
138th Canton Fair Showcases Practical Aesthetics in Home and Garden Innovation
GUANGZHOU, China, Oct. 27, 2025 /PRNewswire/ -- At Phase 2 of the 138th Canton Fair, the Gardening Products and Weaving, Rattan & Iron Products sections are attracting strong interest for their focus on practical aesthetics, merging everyday...
Augmentus Secures Strategic Investment from Applied Ventures to Accelerate AI-Robotics for High-Mix Manufacturing
SINGAPORE and AUSTIN, Texas, Oct. 27, 2025 /PRNewswire/ -- Augmentus, the Singapore-based pioneer in AI-robotics and adaptive automation, today announced a strategic investment from Applied Ventures, LLC, the venture capital arm of Applied...
Innovent's Mazdutide Shows Superiority in Glycemic Control with Weight Loss over Semaglutide in a Head-to-head Phase 3 Clinical Trial DREAMS-3
The proportion of participants achieving HbA1c < 7.0% and a ≥10% reduction in body weight from baseline was 48.0% in the mazdutide group and 21.0% in the semaglutide group DREAMS-3 is the world's first Phase 3 clinical trial of a GCG/GLP-1 dual...
Asia-Pacific Hydrogen Summit & Exhibition 2025 Returns to Sydney as Australia's Largest Dedicated Hydrogen Event
Over 3,000 global leaders, 100+ exhibitors and high-level government participation to accelerate hydrogen's role in the energy transition. SYDNEY, Oct. 27, 2025 /PRNewswire/ -- The Asia-Pacific Hydrogen Summit & Exhibition 2025 taking place...